Ubiquitin C-Terminal Hydrolase-L1 (UCH-L1) in Prediction of Computed Tomography Findings in Traumatic Brain Injury; a Meta-Analysis

被引:6
|
作者
Ramezani, Fatemeh [1 ]
Bahrami-Amiri, Amir [2 ]
Babahajian, Asrin [3 ]
Nia, Kavous Shahsavari [4 ]
Yousefifard, Mahmoud [1 ]
机构
[1] Iran Univ Med Sci, Fac Med, Physiol Res Ctr, Tehran, Iran
[2] Iran Univ Med Sci, Occupat Med Res Ctr, Tehran, Iran
[3] Kurdistan Univ Med Sci, Liver & Digest Res Ctr, Sanandaj, Iran
[4] Tabriz Univ Med Sci, Rd Traff Injury Res Ctr, Tabriz, Iran
来源
EMERGENCY | 2018年 / 6卷 / 01期
关键词
Ubiquitin C-terminal Hydrolase-L1; Traumatic Brain injuries; Diagnosis; Brain computed tomography;
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Ubiquitin C-terminal hydrolase-L1 (UCH-L1) is one of the promising candidates, with an acceptable diagnostic value for predicting head computed tomography (CT) scan findings. However, there has been a controversy between studies and still, there is no general overview on this. Therefore, the current systematic review and meta-analysis attempted to estimate the value of UCH-L1 in predicting intracranial lesions in traumatic brain injury (TBI). Methods: Two independent reviewers screened records from the search of four databases Medline, Embase, Scopus and Web of Science. The data were analyzed in the STATA 14.0 statistical program and the findings were reported as a standardized mean difference (SMD), summary receiver performance characteristics curve (SROC), sensitivity, specificity, and diagnostic odds ratio with 95% confidence interval (95% CI). Results: Finally, the data of 13 articles were entered into the meta-analysis. The mean serum level of UCH-L1 was significantly higher in patients with CT-positive than in TBI patients with CT negative (SMD = 1.67, 95% CI: 1.12 to 2.23, I2 = 98.1%; p <0.0001). The area under the SROC curve for UCH-L1 in the prediction of intracranial lesions after mild TBI was 0.83 (95% CI: 0.80 to 0.86). Sensitivity, specificity and diagnostic odds ratio of serum UCH-L1 was 0.97 (95% CI: 0.92 to 0.99), 0.40 (95% CI: 0.30 to 0.51) and 19.37 (95% CI: 7.25 to 51.75), respectively. When the analysis was limited to assessing the serum level of UCH-L1 within the first 6 hours after mild TBI, its sensitivity and specificity increased to 0.99 (95% CI: 0.94 to 1.0) and 0.44 (95% CI: 0.38 to 0.052), respectively. In addition, the diagnostic odds ratio of 6-hour serum level of UCH-L1 in the prediction of intracranial lesions was 680.87 (95% CI: 50.50 to 9197.97). Conclusion: Moderate level of evidence suggests that serum/plasma levels of UCH-L1 have good value in prediction of head CT findings. It was also found that evaluation of serum/plasma level of UCH-L1 within the first 6 hours following TBI would increase its predictive value. However, there is a controversy about the best cutoffs of the UCH-L1.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Biokinetic Analysis of Ubiquitin C-Terminal Hydrolase-L1 (UCH-L1) in Severe Traumatic Brain Injury Patient Biofluids
    Brophy, Gretchen M.
    Mondello, Stefania
    Papa, Linda
    Robicsek, Steven A.
    Gabrielli, Andrea
    Tepas, Joseph, III
    Buki, Andras
    Robertson, Claudia
    Tortella, Frank C.
    Hayes, Ronald L.
    Wang, Kevin K. W.
    [J]. JOURNAL OF NEUROTRAUMA, 2011, 28 (06) : 861 - 870
  • [2] BIOKINETIC ANALYSIS OF UBIQUITIN C-TERMINAL HYDROLASE (UCH-L1) IN SEVERE TRAUMATIC BRAIN INJURY PATIENT BIOFLUIDS
    Brophy, Gretchen
    Mondello, Stefania
    Robicsek, Steve
    Gabrielli, Andrea
    Papa, Linda
    Tepas, Joseph
    Buki, Andras
    Wang, Kevin
    Hayes, Ronald
    [J]. JOURNAL OF NEUROTRAUMA, 2009, 26 (08) : A14 - A14
  • [3] Association of Ubiquitin C-Terminal Hydrolase-L1 (Uch-L1) serum levels with cognition and brain energy metabolism
    ZHANG, M.
    CHEN, M. -Y.
    WANG, S. -L.
    DING, X. -M.
    YANG, R.
    LI, J.
    JIANG, G. -H.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (10) : 3656 - 3663
  • [4] Ubiquitin C-terminal hydrolase-L1 (Uch-L1) correlates with gonadal transformation in the rice field eel
    Sun, Jinhua
    Shang, Xuan
    Tian, Yihao
    Zhao, Wei
    He, Yan
    Chen, Ke
    Cheng, Hanhua
    Zhou, Rongjia
    [J]. FEBS JOURNAL, 2008, 275 (02) : 242 - 249
  • [5] Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats
    Liu, Ming C.
    Akinyi, Linnet
    Scharf, Dancia
    Mo, Jixiang
    Larner, Stephen F.
    Muller, Uwe
    Oli, Monika W.
    Zheng, Wenrong
    Kobeissy, Firas
    Papa, Linda
    Lu, Xi-Chun
    Dave, Jitendra R.
    Tortella, Frank C.
    Hayes, Ronald L.
    Wang, Kevin K. W.
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2010, 31 (04) : 722 - 732
  • [6] Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries
    Wang, Kevin K.
    Yang, Zhihui
    Sarkis, George
    Torres, Isabel
    Raghavan, Vijaya
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (06) : 627 - 638
  • [7] A new role for the neuronal ubiquitin C-terminal hydrolase-L1 (UCH-L1) in podocyte process formation and podocyte injury in human glomerulopathies
    Meyer-Schwesinger, C.
    Meyer, T. N.
    Muenster, S.
    Klug, P.
    Saleem, M.
    Helmchen, U.
    Stahl, R. A. K.
    [J]. JOURNAL OF PATHOLOGY, 2009, 217 (03): : 452 - 464
  • [8] Serum concentration of ubiquitin c-terminal hydrolase-L1 in detecting severity of traumatic brain injury
    Siahaan, A. M. P.
    Japardi, I.
    Hakim, A. A.
    [J]. 1ST INT CONF ON TROP MED & INFECT DIS FAC OF MED UNIV SUMATERA UTARA IN CONJUNCTION WITH THE 23RD NATL CONGRESS OF THE INDONESIAN SOC OF TROP & INFECT DIS CONSULTANT AND THE 18TH ANNUAL MEETING OF INTERNAL MED DEPT FAC OF MED UNIV SUMATERA UTARA, 2018, 125
  • [9] Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction
    Bishop, Paul
    Rocca, Dan
    Henley, Jeremy M.
    [J]. BIOCHEMICAL JOURNAL, 2016, 473 : 2453 - 2462
  • [10] The diagnostic values of UCH-L1 in traumatic brain injury: A meta-analysis
    Shahjouei, Shima
    Sadeghi-Naini, Mohsen
    Yang, Zhihui
    Kobeissy, Firas
    Rathore, Disa
    Shokraneh, Farhad
    Blackburn, Spiros
    Manley, Geoff T.
    Wang, Kevin K. W.
    [J]. BRAIN INJURY, 2018, 32 (01) : 1 - 17